Drug Profile
Research programme: vaccines - ValiRx
Latest Information Update: 28 Mar 2020
Price :
$50
*
At a glance
- Originator FIT Biotech
- Class Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Ebola virus infections; Human papillomavirus infections; Tuberculosis
- Discontinued Dengue; Diabetes mellitus; Hepatitis C; Malaria; Malignant melanoma
Most Recent Events
- 28 Mar 2020 No recent reports of development identified for preclinical development in Ebola-virus-infections in Finland
- 28 Mar 2020 No recent reports of development identified for preclinical development in Human-papillomavirus-infections in Finland
- 28 Mar 2020 No recent reports of development identified for preclinical development in Tuberculosis in Finland